Edgewise Therapeutics Inc... (EWTX)

22.05

-1.22 (-5.24%)

At close: Mar 31, 2025, 3:59 PM

22.16

0.52%

After-hours: Mar 31, 2025, 05:12 PM EDT

Edgewise Therapeutics Cash Flow Statement

Table Mode

Year	FY24	FY23	FY22	FY21	FY20	FY19
Net Income	-133.81M	-100.16M	-67.64M	-42.81M	-17.12M	-9.71M
Depreciation & Amortization	2.29M	1.73M	538K	272K	185K	123K
Stock-Based Compensation	24.71M	17.56M	10.92M	4.4M	354K	77K
Other Working Capital	8.59M	-1.47M	4.04M	1.98M	1.43M	59K
Other Non-Cash Items	-12.54M	-9.52M	-543K	2.29M	203K	48K
Deferred Income Tax	n/a	n/a	n/a	-2.29M	-203K	-48K
Change in Working Capital	10.33M	-1.56M	4.09M	4.63M	1.95M	334K
Operating Cash Flow	-109.03M	-91.95M	-52.63M	-33.51M	-14.63M	-9.17M
Capital Expenditures	-1.31M	-5.75M	-5.55M	-668K	-203K	-180K
Acquisitions	n/a	n/a	65.03K	241.56K	n/a	n/a
Purchase of Investments	-477.06M	-255.87M	-292.39M	-288.2M	-24.18M	n/a
Sales Maturities Of Investments	293.71M	364.5M	227.36M	46.64M	n/a	n/a
Other Investing Acitivies	n/a	n/a	-65.03K	-241.56K	-24.18K	n/a
Investing Cash Flow	-184.66M	102.89M	-70.58M	-242.23M	-24.38M	-180K
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	10.11M	1.26M	474K	236K	120.28M	24.8M
Financial Cash Flow	249.25M	53.17M	129.64M	186.38M	120.28M	24.8M
Net Cash Flow	-44.43M	64.1M	6.43M	-89.35M	81.26M	15.45M
Free Cash Flow	-110.34M	-97.69M	-58.18M	-34.17M	-14.84M	-9.35M